Debby is a writer and editor with more than 20 years of experience. She currently writes and edits reports, journal manuscripts, peer-review summary statements, Web content, and patient-education materials, primarily in the medical field.

She has worked on documents in such diverse medical fields as cancer (including breast, pancreatic, prostate, gynecologic, and brain), diabetes, cardiovascular disease, epidemiology, health services research, hematologic disease, mental illness, organ transplant, and substance abuse.

Debby holds a B.A. from the University of Western Ontario and a Ph.D. in philosophy from Brown University.

Roshawn is a healthcare-policy executive with experience from the perspective of the patient, provider, and manufacturer. Roshawn spent many years at Amgen in strategic-marketing roles of increasing responsibility. Her final role was as a director in Amgen's Washington, DC, global government affairs office.

Roshawn was responsible for strategy for the Centers for Medicare and Medicaid Services across Amgen's oncology portfolio. She also worked in Amgen's strategic planning, analysis, pricing, and reimbursement departments.

She has held the position of Global Director, Health Economics and Reimbursement in the cardiology franchise of Johnson and Johnson, where her team was responsible for health-economics analysis and reimbursement strategy for 20 countries.

As Vice President of Strategy, Planning and Communication at Long Beach Memorial Medical Center and Miller Children's Hospital, the largest private hospital system west of the Mississippi River, Roshawn held responsibility for business development, marketing, and physician partnerships.

She was a management consultant at The Boston Consulting Group, and is a lecturer on healthcare policy.

Roshawn graduated from Northwestern University's Kellogg Graduate School of Management. She has a degree in international and public affairs from the Woodrow Wilson School at Princeton University.

Paloma comes to 1798 Consultants with an extensive legal background, having been a practicing attorney for twenty years.  With a breadth of experience from litigating in courtrooms to speaking at town hall meetings, Paloma's passion for the United States Constitution is evident throughout her work.  Areas of particular emphasis include the foundations and applications of civil liberties, such as the privacy of patient medical records. 

Paloma is a recent author of a major White Paper on the impending Office of Civil Rights HIPAA compliance audits that is being touted as "seminal" in the field.

Paloma also teaches in the field of American politics at the Rochester Institute of Technology. 

Paloma's undergraduate studies in political science and economic theory were undertaken at Wheaton College (MA), where she received her Bachelor of Arts, magna cum laude.  Paloma was elected by her college faculty to Phi Beta Kappa, an academic honor given to less than 1% of college graduates nationwide.  Paloma earned her Juris Doctor at SUNY Buffalo, and was admitted to practice law in New York in 1992.

Liz joined 1798 Consultants after spending 17 years in the healthcare industry at a variety of pharmaceutical and biotechnology companies, as well as a healthcare consulting company.

Liz was Director of Commercial Information and Sales Operations at Genentech. In this role, she led a team that provided sales, marketing, and reimbursement reporting and analysis to the commercial organization. She and her team supported multiple product launches, brand-performance reporting across products, and the development of new capabilities to support expanded commercial reporting and analytics.

Prior to joining Genentech, Liz worked at Amgen in a variety of roles in marketing, information management, and sales operations and analysis. In Sales Operations, she led a team that supported sales reporting and analysis, customer targeting and segmentation, incentive compensation, sales force sizing and structure, and sales force automation.  She also led the definition and implementation of launch tactics to support the launch of Aranesp® (darbepoetin alpha). In marketing, Liz drove the development of the Aranesp 3-year brand plan and lifecycle plan, developed and implemented a new patient-based forecast model, identified key brand-performance indicators and metrics to measure brand performance, and led the implementation of a medical-information call center.

Prior to her work at Amgen, Liz spent more than 7 years at Muro Pharmaceutical in several positions. Her last position at Muro was head of sales and marketing operations and analysis.

Liz received her B.S. from the University of Massachusetts, Amherst. She also received a certificate in executive development from the Kellogg School of Management.

Andrew joined 1798 Consultants after spending 21 years in the healthcare industry at a variety of the largest and most successful pharmaceutical and biotechnology companies.

Prior to joining 1798 Consultants, Andrew served as Vical's Vice President of Corporate Development.  During his tenure, Vical completed distribution agreements for Vical's most advanced program, Allovectin®.

Prior to joining Vical, Andrew served as the Senior Director of Strategy at Biogen Idec, following a two-year assignment overseeing the commercial development of Zevalin®, the first radioimmunotherapy product approved for use in the United States.

Before joining Biogen Idec, Andrew spent the prior year at MedImmune, where he directed marketing efforts for the FluMist® inhaled influenza vaccine.

Andrew has also served in a variety of marketing positions at the world's largest biotechnology company, Amgen.  During his tenure at Amgen, Andrew helped contribute to the success of Enbrel®, Aranesp®, and Epogen®.

Andrew began his career helping to launch TAP Pharmaceuticals' blockbusters Lupron® and Prevacid®.  Andrew earned a bachelor of science degree in engineering from the United States Military Academy at West Point.

Matthew is a business development professional with ten years of experience in sales, marketing, and client relations.

Prior to joining 1798 Consultants, Matthew was responsible for new account acquisition, marketing communications and strategy, public relations, and existing client management at The Aequitas Group, a biopharmaceutical reimbursement and commercialization consultancy.

In addition, Matthew was the lead developer for the World Hospital Monitor strategic initiative. Leveraging this experience, Matthew provides a unique perspective on the development of the healthcare industry in the United States and competing global alternatives.

Prior to joining The Aequitas Group, Matthew co-founded Medical Tourism Solutions, a medical tourism intermediary offering affordable surgical care overseas. In this role, he cultivated relationships with surgeons, hospitals, government agencies, and logistical support personnel to deliver high-quality medical and support services to international clients.

Matthew completed his M.B.A. at the University of California, San Diego, Rady School of Management. He received his B.A. in economics from Willamette University.

Bob has a unique blend of consulting, academic, and pharmaceutical-industry experience in health economics and outcomes research, strategic pricing, and public policy. He is presently Professor of Pharmaceutical Sciences and Director of Graduate Studies at Texas A&M University Health Sciences Center. Previously, he headed global and U.S. health economics and public policy functions at AstraZeneca, Sterling Winthrop (now Sanofi-Aventis), G.D. Searle, and The Upjohn Company (now Pfizer), where he directed economic evaluations for all major therapeutic categories in all major markets and customer segments. Bob is the author of more than 70 publications, monographs, book chapters, and white papers. He is also the editor of the Journal of Pharmaceutical Finance, Economics & Policy.

Bob holds a Ph.D. and M.S. in health care administration and a B.S. in pharmacy from the University of Mississippi.

Bill joined The 1798 Consultants after spending 22 years at Novartis, Amgen and Allergan in functions that spanned from selling pharmaceuticals to developing access strategies for biologics and devices.  Most recently, Bill was Director of Medical Benefit Marketing at Allergan. In this role, he led a team that created strategy, tactics and tools to support optimal policy language in the Allergan injectable/device portfolio. Bill and his team supported both payor and provider reimbursement initiatives, multiple product and label expansion launches, brand-planning and competitive offense against new toxin approvals. Additionally, Bill worked directly with the State Government Affairs team, Healthcare Policy team and external employer consultants to expand coverage to bariatric surgery.
 
Prior to joining Allergan, Bill worked at Amgen as a Medicare Account Specialist in the Midwest, Payor Marketing Manager to the Medicare team and finally as the Director of Value Access to the Aranesp Oncology franchise.   Bill led the efforts with Global Health Economics to shore up the Aranesp value proposition to mitigate the ESA market decline and co-authored two abstracts on the role of supportive care in "The Working Cancer Patient."  Bill also initiated and led the re-branding and automization efforts of the Amgen reimbursement support services to the current "Amgen Assist" offering.  Preceding Amgen, Bill had a distinguished sales career at Novartis, that included launching unprecedented technology, Apligraf, in the Southwest and laying the groundwork for commercialization in the Latin American market.
 
Bill received his BS at Colorado State University.  Bill also received a certificate in executive development from the Kellogg School of Management.

As a part-time consultant, Jim brings over 20 years of pharmaceutical experience with Amgen with the last ten years evaluating different aspects of reimbursement, payment policy, pricing and contracting, and patient assistance.  For the past three years, as Director of Pricing and Contracting, Jim focused on Sarbannes-Oaxley (SOX) compliance for discount accruals and estimating the impacts of Patient Protection Affordable Care Act (PPACA) individually by product and collectively for all government pricing programs.  He also participated in government price reporting and forecasting of ASP for Amgen.
 
In addition, Jim was previously President of The Safety Net Foundation and the ENcourage Foundation, two Amgen sponsored free drug foundations, from 2006 through 2008.  In this role, Jim re-engineered the business process while improving patient care and realizing significant operational savings.
 
Jim is currently a board member of the local chapter of The Wellness Community, a cancer support organization that provides services to patients, care givers, family members and children.
 
Jim has a Ph.D. in Mineral Economics from the Colorado School of Mines, a MBA in Statistics and Operations Research from University of Denver, and a BA from the University of Rochester in Economics and Statistics.

Wendy is a clinical specialist in drug information within the Division of Pharmacy at the University of Texas MD Anderson Cancer Center. She also holds appointments as an adjunct clinical assistant professor in the Department of Clinical Sciences and Administration at the University of Houston College of Pharmacy and as a clinical instructor at the University of Texas at Austin.  Wendy is a licensed pharmacist in both Texas and Florida and is a board-certified pharmacotherapy specialist.

Before joining MD Anderson, Wendy worked as a clinical specialist in drug information and formulary management at the Methodist Hospital in Houston.

Wendy is active in several local, state, and national organizations. She served as chair-elect Drug Information PRN Group of the American College of Clinical Pharmacy and in 2002 was the recipient of the Pharmacy Resident Medication Safety Grant of the American College of Clinical Pharmacy.

Wendy serves on several institutional committees related to drug-use policy and medication safety. She also serves as a preceptor for MD Anderson's specialty pharmacy practice residency programs, as well as a preceptor for pharmacy students.

Wendy received her doctorate of pharmacy from the University of Louisiana, Monroe, in 2002. She then completed a pharmacy practice residency and drug information pharmacy practice residency at Shands Hospital at the University of Florida.

James brings specialized skills in applied quantitative and analytical frameworks to 1798 Consultants.  His expertise in process driven analytics is used when performing policy or database analysis using The Centers for Medicare and Medicaid Services information.

Prior to 1798 Consultants, James worked as a Senior Analyst at The Aequitas Group, a biopharmaceutical consultancy with an emphasis on reimbursement and commercialization.
Prior to joining The Aequitas Group, James worked on pharmaceutical research using ultra-high-throughput assay technology at a San Diego biotechnology firm. While completing degrees in biotechnology and economics, James worked as a researcher in the University of California, San Diego's bioengineering department. His work in support of cellular biophotonics was recognized as critical in the application of a laser optical trapping system to the study of cellular biochemical pathways and was subsequently published in the Journal of Cell Physiology.

Hafsa brings strong experience in the reimbursement and health economics consulting space to 1798 Consultants.  Hafsa has a master's degree in pharmacy administration, with an emphasis on health-outcomes research, epidemiology, and biostatistics. As a graduate of the University of the Sciences in Philadelphia, Hafsa is well trained to adapt to the many changes that affect our healthcare system. Prior to joining 1798 Consultants, Hafsa was a Senior Analyst at The Aequitas Group, a biopharmaceutical consultancy with an emphasis on applied solutions in reimbursement and commercialization.

Before joining The Aequitas Group, Hafsa coordinated publications and course design and development at the University of the Sciences in Philadelphia.

Hafsa is an experienced healthcare database analyst who is extensively trained in Statistical Analysis System (SAS), Statistical Package for the Social Sciences (SPSS), and Stata (general-purpose statistical software package). Hafsa is also skilled in accessing and manipulating various public-payor databases, such as the Medical Expenditure Panel Survey and other Agency for Healthcare Research and Quality databases, the National Ambulatory Medical Care Survey, the Centers for Disease Control and Prevention databases, and the Centers for Medicare and Medicaid Services' Limited Data Set files.